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Abstract
The clinical application of stem cells in tissue engineering and regeneration is becoming 
more significant. However, its application has been limited by issues like reproducibility 
of the stem cells, ethical concerns of harvesting some of these stem cells, and controlling 
the fate of stem cells in vitro and in vivo. The advent of tissue engineering and regen-
eration has led to the fabrication of advanced biomaterials and scaffolds with enhanced 
ability to mimic and control the cellular microenvironment similar to that of innate stem 
cell niche. Combining the use of stem cells with biomaterials and scaffolds especially 
synthetic hydrogels that have exhibited physicochemical abilities and properties similar 
to native niche can be the future of tissue engineering in terms of formation of new tis-
sues like bones. Recently, there has an increase in the use of either endothelial progenitor 
cells (EPCs), induced pluripotent stem cells (iPSCs), or adult mesenchymal stem cells 
in preclinical studies: however this is yet to be transferred to clinical setups as there are 
limitations in terms of regulations and ethical considerations. The purpose of this review 
is to give comprehensive details about the application of stem cells in tissue engineering.
Keywords: endothelial progenitor cells, induced pluripotent stem cells, adult 
mesenchymal stem, tissue engineering, scaffolds
1. Introduction
Tissue engineering is a multidisciplinary science that applies the principles of bioengineering 
for the fabrication of new and improved biomaterials capable of maintaining and restoring the 
functionality of organs and tissues impaired by disease and trauma. This translational approach 
has been applied to develop and design patient-specific tissue grafts that mimic the functional 
properties of native tissues. Three important factors have been accredited to the success of 
tissue engineering: cocultured stem cells, signaling factor, and the bio- fabricated  scaffold. 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The stem cells are capable of differentiating into several types of tissues and organs, while the 
bio-fabricated scaffold provides structural support to the seeded stem cells. Signaling factors 
are responsible for influencing cell phenotype, metabolism, migration, and organization.
Stem cells are undifferentiated cells of embryonic, fetal origin, and they possess the ability to 
give rise to differentiated cells and then finally develop into organs. Stem cell characteristics 
include the ability to self-replicate and renew, clonage forming, and high potency ability [1]. 
In terms of the potency ability of stem cells, stem cells can be totipotent, could differentiate 
into any cell types (pluripotent) [2], and could differentiate into cells that arise from the three 
germ layers—ectoderm, endoderm, and mesoderm—from which organs develop [3].
Stem cells can be categorized broadly into embryonic and adult stem cells and are efficient cell 
sources for tissue regenerative applications. They have also been reported to have the abilities 
to promote tissue homeostasis, growth, and repair, thereby contributing importantly to tissue 
and organ regeneration [4]. Bio-fabricated scaffolds consist of decellularized biomaterials to 
provide structural and anatomical functions to the seeded stem cells, thereby resulting into 
successful formation of specific tissue. In support of the above report, Kang and colleagues 
demonstrated that decellularized scaffolds loaded with autologous adipose-derived stem 
cells (ADSCs) were efficient to repair cartilage defect in an animal model [5]. They concluded 
that decellularized scaffolds loaded with ADSC induced significant and improved cartilage 
tissue repair compared to native cartilage.
2. Mesenchymal stem cells seeded for bone tissue engineering
MSCs are stromal stem cells that are heterogeneous and are derived from several tissue sources 
that include adipose tissue [6], periodontal ligaments [7], bone marrow (Figure 1) [8], umbili-
cal cord (UC) [9], placenta [10], and lungs [11]. MSCs express surface markers like CD73, 
CD44, CD90, and CD105. The most widely known and used MSCs are bone marrow MSCs 
and adipose tissue-derived MSCs isolated and purified from the bone marrow and adipose 
tissue, respectively. Briefly, the anatomy of the bone marrow is made up of the parenchyma 
and the stroma part. The parenchyma houses the hematopoietic stem cells, and the stoma 
part consists of the bone marrow stromal cells (MSCs) that have the capability to differentiate 
into several cell lines like osteoblasts, chondrocytes, adipocytes, etc. The clinical use of both 
bone-derived mesenchymal stem cells and adipose stem cells in bone tissue engineering has 
been reported using various models of bone regeneration such as osteogenesis [12, 13], long 
bone defects [14, 15], and calvarial defects [16, 17]. Furthermore, co-administration of stem 
cells with cytokines has been reported to be efficient in bone repair as cytokines and growth 
factors like stromal derived factor-1 (SDF-1) can lead to increased migration and homing of 
stem cells to the defected site [18]. In a similar report by Ho et al., they demonstrated that 
co-administration of stromal-derived factor-1 with BM-MSCs would indirectly enhance bone 
repair by improving migration of innate cells to the site of bone fracture. They concluded 
that BM-MSCs overexpressing SDF-1 were efficient in improving the new bone formation 
during the early stage of fracture healing compared to BM-MSC treatment alone [19]. Genes 
 implicated in fracture healing such as osterix [20], hypoxia-inducible factor-1 [21], and BMP-7 
[22] have all been reported to be efficient in bone formation when transfected with MSCs.
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3. Advances in MSCs and tissue engineering technology
Recently, bone tissue engineering in combination with novel stem cell-based technologies 
is yielding promising results as reported by Syed-Picard and colleagues in their experimen-
tal study that BM-MSC-derived cell sheets could be used to fabricate functional periosteal 
tissue [23]. Briefly, culturing BM-MSCs to hyperconfluence to produce abundant extracellu-
lar matrix to form robust cell sheets generated the BM-MSC-derived cell sheets. The authors 
reported that the generated cell sheets supported with calcium phosphate pellets were trans-
planted subcutaneously into mice for 8 weeks. They concluded that there was significant 
bone-like tissue formation by the BM-MSC-calcium phosphate pellet structure compared to 
the non-seeded calcium phosphate scaffold.
In another similar study by [24], BM-MSC cell sheet technology was compared to control cell com-
plex. The authors reported that BM-MSC cell sheet resulted into significant expressed levels of 
growth factors crucial to bone development like vascular endothelial growth factor and PDGF. In 
another innovative study of stem cell application in tissue engineering, Ren et al. fabricated 
Figure 1. Showing in vivo and in vitro stem cell application in engineered tissue (a) In vitro prevascularization methods 
induce cell-seeded scaffolds to form vasculature (b) In vivo ectopic prevascularization involves implantation of a cell-
seeded scaffold into a highly vascularized bed. Adapted from [26] with copyright permission.
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